Cipla Ltd

NSE: CIPLA · BSE: 500087 · Pharmaceuticals & Biotechnology · 44 announcements

Share price: ₹1,333.00
Market cap: ₹1,07,689 Cr
Revenue (annual): ₹28,163 Cr
Net profit (annual): ₹3,879 Cr
P/E (TTM): 31.9×Sector 47.4×
Promoter holding: 29.21%+0.00% QoQ
FII holding: 20.20%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Employee Stock Options 2 Acquisition 2 Partnership 1 Merger & Restructuring 1 Management Change 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

31 Aug 2026 15:42 IST BSE

PartnershipAlfa Alert

Cipla Partnership

Cipla signed an exclusive licensing and supply agreement with SBP Group’s CTTQ for the drug Rolditamig Deuderuxtecan. This collaboration aims to accelerate therapy access in licensed markets.

Read the filing ↗